search

Active clinical trials for "Neuroectodermal Tumors"

Results 61-70 of 137

IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive...

Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUnspecified Childhood Solid Tumor1 more

This phase I clinical trial is studying the side effects and best dose of IMC-A12 in treating young patients with relapsed or refractory Ewing sarcoma/peripheral primitive neuroectodermal tumor or other solid tumors. Monoclonal antibodies, such as IMC-A12, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them.

Completed49 enrollment criteria

Ixabepilone in Treating Young Patients With Refractory Solid Tumors

Adult RhabdomyosarcomaAdult Synovial Sarcoma11 more

This phase II trial is studying how well ixabepilone works in treating young patients with refractory solid tumors. Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Completed69 enrollment criteria

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell Tumor24 more

This phase I trial is studying the side effects and best dose of ispinesib in treating young patients with relapsed or refractory solid tumors or lymphoma. Drugs used in chemotherapy, such as ispinesib, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing

Completed48 enrollment criteria

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized...

Ewing Sarcoma of BoneLocalized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

This clinical trial is studying the side effects of combination chemotherapy and to see how well they work in treating patients with newly diagnosed localized Ewing sarcoma family of tumors. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) and giving the drugs in different ways may kill more tumor cells.

Completed40 enrollment criteria

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous...

Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell Tumor24 more

This phase II trial is studying how well oxaliplatin works in treating young patients with recurrent solid tumors that have not responded to previous treatment. Drugs used in chemotherapy, such as oxaliplatin, work in different ways to stop tumor cells from dividing so they stop growing or die.

Completed60 enrollment criteria

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

Childhood Chronic Myelogenous LeukemiaChildhood Desmoplastic Small Round Cell Tumor12 more

This phase I trial is studying the side effects and best dose of tanespimycin in treating young patients with recurrent or refractory leukemia or selected solid tumors. Drugs used in chemotherapy, such as tanespimycin, work in different ways to stop cancer cells from dividing so they stop growing or die.

Completed78 enrollment criteria

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell Tumor24 more

This phase I trial is studying the side effects and best dose of FR901228 in treating children with refractory or recurrent solid tumors or leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die

Completed55 enrollment criteria

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive...

Brain and Central Nervous System Tumors

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating children who have recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal or atypical teratoid rhabdoid tumor.

Completed59 enrollment criteria

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma...

Adult Alveolar Soft-part SarcomaAdult Angiosarcoma18 more

This phase II trial studies how well depsipeptide (romidepsin) works in treating patients with metastatic or unresectable soft tissue sarcoma. Drugs used in chemotherapy, such as depsipeptide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Completed70 enrollment criteria

Cilengitide in Treating Children With Refractory Primary Brain Tumors

Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor24 more

This phase I trial is studying the side effects and best dose of cilengitide in treating children with recurrent, progressive, or refractory primary CNS tumors. Cilengitide may slow the growth of brain cancer cells by stopping blood flow to the tumor.

Completed23 enrollment criteria
1...678...14

Need Help? Contact our team!


We'll reach out to this number within 24 hrs